Bevacizumab ( Avastin)

DRUG3 trials

Sponsors

Narayana Nethralaya, Sun Yat-sen University, Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Conditions

Colorectal Cancer MetastaticHepatocellular CarcinomaMacular OedemaProliferative Diabetic RetinopathyWet AMD

Phase 1

ctDNA-Guided Cetuximab or Bevacizumab Plus Trifluridine/Tipiracil in RAS/BRAF Wild-Type mCRC

RecruitingNCT07012954

Sun Yat-sen UniversityColorectal Cancer Metastatic

Start: 2025-06-01End: 2030-12-31Target: 64Updated: 2025-06-24

Phase 3

ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced Hepatocellular

Not yet recruitingNCT07813572

Suzhou Zelgen Biopharmaceuticals Co.,LtdHepatocellular Carcinoma

Start: 2026-09-01End: 2032-09-01Target: 600Updated: 2026-09-10

Unknown Phase

Intravitreal Bevacizumab for Retinal Disorders

Narayana NethralayaMacular Oedema, Proliferative Diabetic Retinopathy, Wet AMD

Start: 2006-08-31End: 2006-11-30Target: 150Updated: 2006-11-23